Health Catalyst, Inc. announced impairment charges for the first quarter ended March 31, 2024. For the quarter, the company reported impairment of long-lived assets of $2,200,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.73 USD | +1.20% | -3.17% | -27.32% |
May. 10 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
May. 09 | Health Catalyst Seeks M&A | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.32% | 393M | |
-20.31% | 217B | |
-19.98% | 69.21B | |
-0.09% | 58.3B | |
-11.74% | 46.03B | |
+1.83% | 40.85B | |
-1.28% | 35.93B | |
-8.75% | 28.65B | |
+106.15% | 26.08B | |
+4.60% | 21.87B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Health Catalyst, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024